Intravenous bisphosphonates for postmenopausal osteoporosis

Numerous clinical studies have shown bisphoshonates (BPs) to be useful and cost-effective options for the fractures prevention and postmenopausal bone loss. The use of oral bisphoshonates is an established option for managment of osteoporosis in postmenopausal women, but many of them complaint from...

Descripción completa

Detalles Bibliográficos
Autor principal: Mottaghi, Peyman
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082804/
https://www.ncbi.nlm.nih.gov/pubmed/21526078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082804/
https://www.ncbi.nlm.nih.gov/pubmed/21526078

Ejemplares similares